Company intelligence / Profile preview

System Art Holdings

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

System Art Holdings is a Hong Kong-based investment holding company. While the name may suggest a connection to systemic biology or healthcare technology, the entity primarily operates as a vehicle for investment and corporate holdings rather than as a dedicated life sciences or biotechnology firm. It does not maintain a drug development pipeline or proprietary therapeutic platforms. The company is not recognized as a participant in the clinical-stage biotech or pharmaceutical sectors.

Industry: Investors

Beyond the preview

Go deeper on System Art Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on System Art Holdings.

Explore the full profile